Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Feb 1;13(1):112-114.
doi: 10.21037/hbsn-23-612. Epub 2024 Jan 16.

A journey of a thousand miles begins with one small step

Elke Roeb  1
Affiliations
Editorial

A journey of a thousand miles begins with one small step

Elke Roeb. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: Metabolism-associated steatosis liver disease (MASLD); exercise; fatty liver; metabolism-associated fatty liver disease (MAFLD); non-alcoholic fatty liver disease (NAFLD).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-23-612/coif). The author reports a grant from German Research Foundation (DFG; grants DFG AZ RO957/13-1) and he is a speaker for Abbvie, Falk Foundation, BMS, Gilead, Intercept and Norgine and has received consultancy fees from Pfizer and Merz. The author has no other conflicts of interest to declare.

Comment on

References

    1. Paik JM, Henry L, Younossi Y, et al. The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019. Hepatol Commun 2023;7:e0251. 10.1097/HC9.0000000000000251 - DOI - PMC - PubMed
    1. Gehrke N, Schattenberg JM. Metabolic Inflammation-A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease? Gastroenterology 2020;158:1929-1947.e6. 10.1053/j.gastro.2020.02.020 - DOI - PubMed
    1. Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 2023;79:1542-56. 10.1016/j.jhep.2023.06.003 - DOI - PubMed
    1. Roeb E, Canbay A, Bantel H, et al. Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025. Z Gastroenterol 2022;60:1346-421. 10.1055/a-1880-2283 - DOI - PubMed
    1. Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. Gastroenterology 2015;149:367-78.e5; quiz e14-5. 10.1053/j.gastro.2015.04.005 - DOI - PubMed